-
Legacy of the 1918 influenza pandemic
Tuesday, November 3, 2020The 1918-1919 influenza epidemic killed more than 50 million people and infected between one fifth and half of the world’s population.
-
New Zeiss solutions
Monday, November 2, 2020At the 38th Congress of the ESCRS in Amsterdam, Carl Zeiss Meditec (Jena, Germany) officially launched the IOLMaster 700 with Central Topography (CT)
-
Chandelier solution
Monday, November 2, 2020Oertli has announced the release of two trocar-based chandelier solutions that also offer a one-step access for an easy and quick connection.
-
New ablation laser
Monday, November 2, 2020ZIEMER Ophthalmic Systems has received CE mark clearance for its new ablation laser. “AQUARIUZ”, a newly engineered, compact solid-state ablation laser for refractive surgery.
-
AbbVie acquires Allergan
Monday, November 2, 2020On 8 May, 2020, AbbVie (North Chicago, Illinois, USA), a research-based global biopharmaceutical company, announced completion of its acquisition of Allergan plc.
-
Editorial: Paradigm Shift
Monday, November 2, 2020Ken Nischal MD, FRCOphth says the COVID-19 pandemic has transformed completely the way we live our lives and the way we practise as ophthalmologists
-
Dr Jennifer Kim wins John Henahan Prize
Friday, October 23, 2020The winner of this year’s John Henahan Prize is Dr Jennifer Kim, a Specialist Registrar at the Manchester Royal Eye Hospital, UK.
-
IOL’S EXTENDED DIOPTRE RANGE
Thursday, October 1, 2020AcuFocus, Inc. has announced that the IC-8 small aperture intraocular lens (IOL) power range now extends from +10.0D to +30.0D (0.50D steps). “Having the IC-8 IOL in my practice has provided an exceptional option for my patients who are looking for spectacle independence,” says Professor Sathish Srinivasan, cataract and refractive surgery specialist at University Hospital […]
-
Back to work
Thursday, October 1, 2020Maternity leave and lockdown have similar effects on out-of-practice surgeons
-
Santen Vision 2030
Thursday, October 1, 2020MicroShunt pending FDA approval exemplifies new focus on unmet patient need
